China Pharma Holdings EV - Enterprise Value 2011-2026 | CPHI

Annual EV - Enterprise Value China Pharma Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009
10.7 M	6.97 M	8.84 M	11.8 M	14 M	43.1 M	30.2 M	26.6 M	29.7 M	27.8 M	24.4 M	33.6 M	37.4 M	21.6 M	42.9 M	59.3 B	30 B

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
59.3 B	6.97 M	5.27 B

EV - Enterprise Value of other stocks in the Drug manufacturers industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Endo International plc ENDP	-710 M	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	-3.12 M	-	-	$ 36.6 M	USA
Cumberland Pharmaceuticals CPIX	126 M	$ 5.6	-	$ 83.2 M	USA
HEXO Corp. HEXO	560 M	-	2.45 %	$ 38.1 M	Canada
Calliditas Therapeutics AB (publ) CALT	-974 M	-	-0.1 %	$ 2.03 B	Schweden
AcelRx Pharmaceuticals ACRX	6.79 M	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	-11 M	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	28.5 M	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	737 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	25.3 M	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	197 M	-	-	$ 142 M	USA
Cronos Group CRON	-1.35 M	$ 2.63	-1.87 %	$ 1.01 B	Canada
Athenex ATNX	209 M	-	-23.39 %	$ 1.76 M	USA
Harrow Health HROW	2.21 B	$ 38.93	3.43 %	$ 1.43 B	USA
Avadel Pharmaceuticals plc AVDL	756 M	-	-	$ 2.06 B	France
Catalent CTLT	16.7 B	-	-	$ 11.5 B	USA
Organogenesis Holdings ORGO	408 M	$ 2.41	2.99 %	$ 305 M	USA
Eagle Pharmaceuticals EGRX	457 M	-	-39.89 %	$ 27.7 M	USA
Pacira BioSciences PCRX	1.68 B	$ 22.74	-1.09 %	$ 1.05 B	USA
Canopy Growth Corporation CGC	349 M	$ 0.98	-1.71 %	$ 105 M	Canada
Sonoma Pharmaceuticals SNOA	7.57 M	$ 1.11	1.83 %	$ 1.38 M	USA
Aurora Cannabis ACB	330 M	$ 2.95	-2.96 %	$ 162 M	Canada
Solid Biosciences SLDB	616 M	$ 7.36	3.08 %	$ 644 M	USA
Jupiter Wellness JUPW	3.7 M	-	-	$ 33.6 M	USA
Lannett Company LCI	671 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	146 M	$ 1.03	-2.83 %	$ 98.2 M	Canada
Tilray TLRY	1.96 B	$ 5.01	0.6 %	$ 3.1 B	Canada
Evolus EOLS	467 M	$ 6.75	0.3 %	$ 435 M	USA
Sundial Growers SNDL	-17.5 M	$ 1.43	0.7 %	$ 3.37 M	Canada
Emergent BioSolutions EBS	1.04 B	$ 8.29	-0.36 %	$ 444 M	USA
Veru VERU	80.7 M	$ 3.13	4.33 %	$ 45.8 M	USA
Neoleukin Therapeutics NLTX	-80.1 M	-	-	$ 193 M	Canada
cbdMD YCBD	4.51 M	$ 0.67	-2.33 %	$ 2.7 M	USA
Assertio Holdings ASRT	238 M	$ 23.5	0.09 %	$ 150 M	USA
ProPhase Labs PRPH	56.3 M	-	-	$ 5.07 M	USA
Radius Health RDUS	715 M	-	-	$ 1.42 B	USA
Bausch Health Companies BHC	26.7 B	$ 4.99	-1.38 %	$ 1.85 B	Canada
PetIQ PETQ	280 M	-	1.64 %	$ 400 M	USA
Relmada Therapeutics RLMD	251 M	$ 6.37	-4.21 %	$ 251 M	USA
Recro Pharma REPH	220 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	84.7 M	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	26.3 M	$ 4.09	-3.31 %	$ 204 M	USA
PLx Pharma PLXP	75 M	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	21.2 B	$ 16.32	-0.97 %	$ 19 B	USA
Zomedica Corp. ZOM	2.62 M	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	-22.6 M	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	43.3 M	$ 0.64	2.74 %	$ 23 M	USA
Tricida TCDA	555 M	-	-	$ 3.25 M	USA
TherapeuticsMD TXMD	26.3 M	$ 2.28	3.64 %	$ 26.4 M	USA